This Retailer Among is Our 4 Momentum Stocks to Watch

Harry Boxer  |

Image via Mike Mozart/Flickr CC

Today’s top charts to watch include a specialty retailer and an e-commerce company in addition to two drug makers.

Abercrombie & Fitch Co. ANF gained 79 cents to $26.36 on 1.3 million shares Tuesday on no news. The stock, which is in a 1-year up-channel, tested rising trend line support in early June and again recently. Tuesday’s move broke it out of a declining wedge, with the June high near $28.75 the next target, followed by the low $30’s.

Arrowhead Pharmaceuticals, Inc. ARWR jumped 65 cents to $16.45 on 1 million shares traded Tuesday. The move came on no news from the developer of RNA interference drugs. The stock has been in a week-long flag after its breakout from another flag during what has been a steep ascent since early May. A move through Monday’s high near $16.75 could propel the stock to the channel top near $22.

Etsy, Inc. ETSY advanced $1.34 to $44.25 on 1.2 million shares Tuesday. The e-commerce company saw its shares pop in June on improved guidance and a roll out of its new user toolkit, and it has since been in a high-level consolidation. A break above recent highs at about $45.50 could accelerate the stock to $52-$53.

Zafgen, Inc. ZFGN rose 52 cents to $10.56 on 444,800 shares Tuesday. There was no news from the company, which develops therapies for patients suffering from metabolic diseases. Tuesday’s move broke the stock out of a mini flag that had followed its steep advance since late June. A break of recent highs near $11.25 could get the stock to $12.75 next.

See Harry's video chart analysis on these stocks.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

DISCLOSURE: No holdings.


The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Market Movers

Sponsored Financial Content